News

Delgocitinib cream recently became the first FDA-approved treatment for chronic hand eczema. Robert Spurr of LEO Pharma shares insights into what it means for providers and patients.

This review of the latest dermatologic studies includes insights into emerging terbinafine resistant trichophyton dermatophytosis, clinicodemographic features and usage of oral immunosuppressive agents in childhood and adolescent vitiligo, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Coates addresses social determinants of health in pediatric dermatology, emphasizing their impact on treatment and patient outcomes.

Lauren Madigan, MD, shares vital insights on complex dermatology, emphasizing accurate diagnoses and the importance of diversity in dermatologic imagery.

At Elevate-Derm Summer, Buchi Neita, MCMSc, PA-C, discussed enhancing dermatologic care for patients with skin of color by recognizing characteristics in common conditions and offered strategies to build rapport with patients.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Nektar Therapeutics advances alopecia areata treatment with FDA's Fast Track designation for rezpegaldesleukin, targeting immune modulation in chronic hair loss.

Johnson & Johnson seeks FDA approval to update guselkumab's label, highlighting its unique ability to significantly inhibit joint damage in active psoriatic arthritis.

Dermatology Times is looking back on the top stories in dermatology from the month of July.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dermatology Times is recapping our exclusive expert interviews from the month of July.

Learn more about the in-depth topics covered in the July 2025 print issue of Dermatology Times.

AI revolutionizes skin care by personalizing product recommendations, enhancing customer satisfaction, and transforming dermatologist-patient interactions for better outcomes.

Young dermatologists should learn essential financial planning strategies to secure their future, including saving early, securing insurance, and budgeting effectively.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Shanna Miranti, MPAS, PA-C, describes her clinical approach for managing moderate to severe pediatric atopic dermatitis and how she selects between the 3 available non-steroidal topicals.

Amy Spizuoco, DO, FAOCD, shares groundbreaking insights on alopecia treatments and emerging STIs at this year's Elevate-Derm Summer Conference, enhancing patient care.

Tina Bhutani, MD, shares vital insights on psoriasis management, sleep's role in dermatology, and new alopecia areata treatments at Elevate-Derm Summer 2025.

Dermatology has the opportunity of directing and leading AI use in the field, according to David Cotter, MD, PhD.

The pediatric dermatology community mourns the loss of Dr Robert Sidbury, a beloved leader and mentor, celebrated for his compassion and groundbreaking contributions.

Catch up on coverage from the third day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

At Elevate-Derm Summer, Shanna Miranti, MPAS, PA-C, highlighted practical strategies for isotretinoin prescribing, addressed the impact of iPLEDGE hurdles, and introduced the SkinSync podcast.

Tips for leveraging the right topical to improve patient outcomes from Linda Stein Gold, MD.

Catch up on coverage from the third day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.

Anisha Patel, MD, highlights dermatology's vital role in cancer care, discussing skin indicators and innovative immunotherapy at her Elevate-Derm Summer sessions.

Eichenfield discussed the ever-evolving armamentarium, and how to navigate changes in the field.

Discover key insights on melanonychia and the transformative potential of artificial intelligence from Ata Moshiri, MD, MPH, FAAD, at Elevate-Derm Summer 2025.

Adam Friedman, MD, shares tips for recognizing and addressing tinea at the DERM 2025 conference.

Traditional mouse models for EBS are limited, prompting Simpson's lab to create more accurate human-based tissue models.